KhanS, SiddiqueR, ShereenMA, et al.Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options. J Clin Microbiol, 2020; 58:e00187-20. DOI: 10.1128/JCM.00187-20.
2.
YuJ, TostanoskiLH, PeterL, et al.DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science 2020 May 20 [Epub ahead of print]; DOI: 10.1126/science.abc6284.
3.
BeigelJH, TomashekKM, DoddLE, et al.Remdesivir for the treatment of Covid-19—preliminary report. N Engl J Med 2020 May 22. DOI: 10.1056/NEJMoa2007764.
4.
AbbottTR, DhamdhereG, LiuY, et al.Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell, 2020; 181:865–876.e12. DOI: 10.1016/j.cell.2020.04.020.
5.
BarrangouR, FremauxC, DeveauH, et al.CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007; 315:1709–1712. DOI: 10.1126/science.1138140.
6.
BrounsSJ, JoreMM, LundgrenM, et al.Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 2008; 321:960–964. DOI: 10.1126/science.1159689.
7.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821. DOI: 10.1126/science.1225829.
8.
GasiunasG, BarrangouR, HorvathP, et al.Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A, 2012; 109:E2579–2586. DOI: 10.1073/pnas.1208507109.
9.
KnottGJ, DoudnaJA. CRISPR-Cas guides the future of genetic engineering. Science, 2018; 361:866–869. DOI: 10.1126/science.aat5011.
10.
AbudayyehOO, GootenbergJS, KonermannS, et al.C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016; 353:aaf5573. DOI: 10.1126/science.aaf5573.
11.
East-SeletskyA, O'ConnellMR, KnightSC, et al.Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature, 2016; 538:270–273. DOI: 10.1038/nature19802.
12.
De ClercqE, LiG. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev, 2016; 29:695–747. DOI: 10.1128/CMR.00102-15.
13.
FreijeCA, MyhrvoldC, BoehmCK, et al.Programmable inhibition and detection of RNA viruses using Cas13. Mol Cell, 2019; 76:826–837.e11. DOI: 10.1016/j.molcel.2019.09.013.
CuiJ, LiF, ShiZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol, 2019; 17:181–192. DOI: 10.1038/s41579-018-0118-9.
16.
KrishnamurthyS, Wohlford-LenaneC, KandimallaS, et al.Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. Nat Commun, 2019; 10:4906. DOI: 10.1038/s41467-019-12922-y.
17.
XuCF, ChenGJ, LuoYL, et al.Rational designs of in vivo CRISPR-Cas delivery systems. Adv Drug Deliv Rev 2019 Nov 21 [Epub ahead of print]; DOI: 10.1016/j.addr.2019.11.005.
